单纯输注抗BCMA与抗BCMA输注联合抗CD19嵌合抗原受体T细胞治疗复发/难治性多发性骨髓瘤免疫重建的对比

OBJECTIVE: We observed and compared the differences in immune reconstruction between single-infusion anti-B-cell maturation antigen（BCMA）, chimeric antigen receptor T cells（CAR-T）, and combined infusion of anti-CD19 CAR-T cells in the treatment of recurrent/refractory multiple myeloma（RRMM）. METHODS...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2021
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607032/
https://www.ncbi.nlm.nih.gov/pubmed/34753227
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.09.004

Ejemplares similares

Ejemplares similares